Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Submitted by
admin
on January 30, 2015 - 11:18am
Source:
Forbes
News Tags:
AbbVie
hepatitis C
Viekira Pak
Headline:
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Do Not Allow Advertisers to Use My Personal information
